Parsons Capital Management Inc F Star Therapeutics, Inc. Transaction History

Parsons Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$2.18 - $6.39 $32,700 - $95,850	15,000 Added 70.45%	36,291 $227,000
Q1 2022 May 02, 2022	SELL	$2.77 - $5.36 $1,628 - $3,151	-588 Reduced 2.69%	21,291 $76,000
Q4 2021 Feb 07, 2022	SELL	$4.71 - $7.38 $8,124 - $12,730	-1,725 Reduced 7.31%	21,879 $110,000
Q3 2021 Nov 09, 2021	BUY	$5.2 - $8.42 $2,470 - $3,999	475 Added 2.05%	23,604 $173,000
Q4 2020 Feb 08, 2021	BUY	$1.03 - $10.39 $23,822 - $240,310	23,129 New	23,129 $228,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Parsons Capital Management Inc with notifications on news.